| scholarly article | Q13442814 |
| P356 | DOI | 10.1530/ERC-10-0235 |
| P8608 | Fatcat ID | release_hjtn6rhowvdwtofrjjmrt6hogi |
| P932 | PMC publication ID | 3043379 |
| P698 | PubMed publication ID | 21263043 |
| P50 | author | Theodore J. Brown | Q46857872 |
| P2093 | author name string | Carl Virtanen | |
| Patricia A Shaw | |||
| Alicia A Tone | |||
| P2860 | cites work | Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship. | Q53337533 |
| The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. | Q53639283 | ||
| Cytoplasmic and nuclear progesterone receptors in human fallopian tube and their relationship to plasma steroids during the menstrual cycle | Q69898007 | ||
| Cyclic changes in cytosol progesterone receptor of human fallopian tube | Q70653302 | ||
| Changes during the menstrual cycle in cytosolic and nuclear concentrations of progestagen receptor in the human Fallopian tube | Q70789671 | ||
| Characterization of progesterone receptor A and B expression in human breast cancer | Q71804872 | ||
| Morphology and ultrastructure of fallopian tube epithelium at different stages of the menstrual cycle and menopause | Q72149813 | ||
| Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status | Q77102021 | ||
| Loss of heterozygosity at 11q22 correlates with low progesterone receptor content in epithelial ovarian cancer | Q77556042 | ||
| Chromosome 11q22.3-q25 LOH in ovarian cancer: association with a more aggressive disease course and involved subregions | Q77593228 | ||
| BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor | Q24555775 | ||
| p300 Modulates the BRCA1 inhibition of estrogen receptor activity | Q28215039 | ||
| Detection of progesterone receptor forms A and B by immunohistochemical analysis | Q28345003 | ||
| Diagnosis of multiple cancer types by shrunken centroids of gene expression | Q29615528 | ||
| A candidate precursor to serous carcinoma that originates in the distal fallopian tube. | Q33264156 | ||
| Gene expression profiles of luteal phase fallopian tube epithelium from BRCA mutation carriers resemble high-grade serous carcinoma | Q33348197 | ||
| Low malignant potential tumors with micropapillary features are molecularly similar to low-grade serous carcinoma of the ovary | Q33527712 | ||
| The breast cancer susceptibility gene BRCA1 regulates progesterone receptor signaling in mammary epithelial cells | Q33652431 | ||
| Progesterone receptor transcription and non-transcription signaling mechanisms | Q34282690 | ||
| Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer. | Q34519901 | ||
| The distal fallopian tube: a new model for pelvic serous carcinogenesis. | Q34601152 | ||
| A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations | Q34761925 | ||
| Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome | Q34999960 | ||
| Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis | Q35098091 | ||
| Diverse tumorigenic pathways in ovarian serous carcinoma | Q35789009 | ||
| Reproductive tissue selective actions of progesterone receptors. | Q35848877 | ||
| Ratio of mRNA expression of progesterone receptor isoforms AB is to B in human oviduct mucosal cells during the ovulatory cycle | Q36269236 | ||
| Expression of human estrogen receptor-alpha and -beta, progesterone receptor, and androgen receptor mRNA in normal and malignant ovarian epithelial cells | Q36367092 | ||
| Progesterone receptor isoforms A and B in human epithelial ovarian carcinoma: immunohistochemical and RT-PCR studies | Q36621572 | ||
| The role and mechanism of progesterone receptor activation of extra-nuclear signaling pathways in regulating gene transcription and cell cycle progression | Q37102649 | ||
| Non-genomic progesterone actions in female reproduction. | Q37303427 | ||
| Candidate serous cancer precursors in fallopian tube epithelium of BRCA1/2 mutation carriers. | Q37526389 | ||
| Differential expression of progesterone receptor isoforms A and B in the normal ovary, and in benign, borderline, and malignant ovarian tumors | Q38363908 | ||
| Expression of differentiation and proliferation related proteins in epithelium of prophylactically removed ovaries from women with a hereditary female adnexal cancer predisposition. | Q38451794 | ||
| Loss of co-ordinate expression of progesterone receptors A and B is an early event in breast carcinogenesis | Q38456582 | ||
| Phosphorylation of progesterone receptor serine 400 mediates ligand-independent transcriptional activity in response to activation of cyclin-dependent protein kinase 2. | Q40486142 | ||
| Progesterone-independent effects of human progesterone receptors (PRs) in estrogen receptor-positive breast cancer: PR isoform-specific gene regulation and tumor biology. | Q40488240 | ||
| Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function | Q41523742 | ||
| Adenocarcinoma of the Fallopian tube. An ultrastructural study | Q41627764 | ||
| Regulation of progesterone receptor-mediated transcription by phosphorylation | Q41710148 | ||
| Progesterone receptor A and B isoforms in the human breast and its disorders | Q43553535 | ||
| Germ-line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen-responsive proteins and the predominance of progesterone receptor A. | Q44734673 | ||
| The activities of progesterone receptor isoform A and B are differentially modulated by their ligands in a gene-selective manner | Q45111424 | ||
| Expression of progesterone receptor is a favorable prognostic marker in ovarian cancer | Q45274570 | ||
| Expression of steroid hormone receptors in BRCA1-associated ovarian carcinomas | Q46403948 | ||
| BRCA-mutation-associated fallopian tube carcinoma: a distinct clinical phenotype? | Q46554691 | ||
| Nuclear progesterone receptor A and B isoforms in mouse fallopian tube and uterus: implications for expression, regulation, and cellular function | Q46921316 | ||
| Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers. | Q51842388 | ||
| P433 | issue | 2 | |
| P921 | main subject | uterine tube | Q1233836 |
| serous carcinoma | Q7455058 | ||
| P304 | page(s) | 221-234 | |
| P577 | publication date | 2011-02-23 | |
| P1433 | published in | Endocrine-Related Cancer | Q3054004 |
| P1476 | title | Decreased progesterone receptor isoform expression in luteal phase fallopian tube epithelium and high-grade serous carcinoma | |
| P478 | volume | 18 |
| Q34456552 | A Novel Subset of Human Tumors That Simultaneously Overexpress Multiple E2F-responsive Genes Found in Breast, Ovarian, and Prostate Cancers |
| Q37513137 | BRCA and Early Events in the Development of Serous Ovarian Cancer. |
| Q37745666 | Effect of menopause on hormonal receptors in ampullae of the fallopian tube with a special reference to the p53 signature. |
| Q33645478 | Glucocorticoid-induced reversal of interleukin-1β-stimulated inflammatory gene expression in human oviductal cells |
| Q64120330 | IGF-axis confers transformation and regeneration of fallopian tube fimbria epithelium upon ovulation |
| Q90378482 | Identification of Hub Genes in High-Grade Serous Ovarian Cancer Using Weighted Gene Co-Expression Network Analysis |
Search more.